Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 8.4B | 7.8B | 7.9B | 7.7B |
Cost of revenue | 4.4B | 4.2B | 4.3B | 4.2B |
Gross profit | 3.9B | 3.7B | 3.6B | 3.5B |
Operating expense | ||||
Research & development | 773M | 746M | 718M | 742M |
Selling general and admin | 1.2B | 1.0B | 1.0B | 885M |
Other operating expenses | 451M | 427M | 436M | 454M |
Operating income | 1.5B | 1.5B | 1.4B | 1.4B |
Non operating interest income | ||||
Income | 148M | 183M | 165M | 166M |
Expense | 97M | 106M | 93M | 86M |
Other income expense | -132M | -220M | -111M | -251M |
Pretax income | 1.4B | 1.3B | 1.4B | 1.2B |
Tax provision | 289M | 301M | 271M | 321M |
Net income | 1.1B | 1.0B | 1.1B | 888M |
Basic EPS | — | 1 | 1.1 | 0.8 |
Diluted EPS | — | 1.0 | 1.1 | 0.8 |
Basic average shares | — | 1.0B | 1.0B | 1.1B |
Diluted average shares | — | 1.0B | 1.0B | 1.1B |
EBITDA | 1.9B | 1.9B | 1.9B | 1.8B |
Net income from continuing op. | 1.1B | 1.0B | 1.1B | 888M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |